Post by ginna898 on Mar 31, 2012 14:09:21 GMT -5
Vetericyn Wound and Infection Care Products are Based on Innovative Technology
Vetericyn is a family of animal wound and infection care products that are as safe as water and are designed to replicate the actions of the animal’s own immune system to fight infections.
Faster healing is achieved when wounds are cleaned and maintained moist. This product has proven facts of non-toxic, broad spectrum antimicrobial in vitro killing bacteria, fungi, spores and viruses including MRSA, E. coli and staph in 30 seconds. Vetericyn is safe enough to use as an eye and ear animal rinse.
Our technology is available in products for both animals and humans.
Innovacyn's wound and infection products are proudly made in the USA. Over two million human patients have been safely treated by our technology worldwide.
vetericyn.com/
www.apwca.org/abstracts/abstract.cfm?ID=273
Title: Cost Effective use of Hypochlorous Acid and its Impact on Bioburden in a Clinical Setting
- Mar 31, 2011
Author(s) Gregory A Bohn
Presented at: APWCA 2011 National Conference
Background
With ever increasing attention on bioburden and emergence of resistant bacteria, our hospital clinic has encouraged a policy of culturing wounds at the time of presentation. Knowing that wounds contain biofilms that harbor bacteria, the dilemma arises then as to whether to treat a wound with antimicrobial dressings or antibiotics when bacteria are identified.
Hypochlorous acid is a product of the neutrophilic oxidative burst process that occurs as part of our immune systems response to invading pathogens.
A product of myeloperoxidase catalyzation within a phagolyposome of the neutrophil, Hypochlorous acid is a potent microbicidal agent.
It has significant activity against a wide variety of aerobic, anaerobic, fungal and viral pathogens.
Hypochlorous acid has been shown to be effective within seconds of exposure to pathogens making it an attractive topical treatment in wound care. Bacterial resistance to antibiotics continues to be problematic as emergence of resistance is common.
1 The topical use of broad spectrum antibiotics is not recommended due to the risk of allergic reaction, greater effect on endogenous microflora, induction of resistance, and reduced therapeutic efficacy.
Similarly, other topical antimicrobial agents have cytotoxic effects and impair wound healing.
2 The ability to penetrate and degrade biofilm formation and the bioburden contained within is an advantageous effect in wound care.
3 We review the effect the use of hypochlorous acid on bioburden and biofilm as monitored in our clinic and compare that to the cost of antimicrobial dressing use.
Methods Results Conclusion
1. 1.) Bergstrom N, Bennett MA, Carlson CE, et al. Treatment of Pressure Ulcers. Clinical Practice Guideline, 2. 2.) Wang L, Bassiri M, Naijafi R, Najafi K, Yang J, Khosrovi B, Hwong W, Barati E, Belisle B, Celeri C, Robson MC. Hypochlorous Acid as a PotentialWound Care Agent Part I. Stabilized Hypochlorous Acid: A Component of the Inorganic Armamentarium of Innate Immunity. Journ Burns and Wounds Vol 6 Apr 2007 pp 65-79. 3. 3.) Robson MC, Payne WG, et al. Hypochlorous Acid as a PotentialWound Care Agent Part II. Stabilized Hypochlorous Acid: Its Role in Decreasing Tissue Bacterial Bioburden and Overcoming the Inhibition of Infection on Wound Healing. Journ Burns and Wounds vol 6 Apr 2007 pp 80-90 4. 4.) Selkon JB, Cherry GW, Wilson JM, Hughes MA, Evaluation of hypochlorous acid washes in the treatment of chronic venous leg ulcers. Journal of Wound Care Vol 15 No1 Jan 2006 pp 33-37. 5. 5.) Woo KY, Sibbald RG, A Cross-sectional Validation Study of Using NERDS and STONEES to Assess Bacterial Burden. Ostomy Wound Management 55(8) 2009. Pp 40-48.
Vetericyn is a family of animal wound and infection care products that are as safe as water and are designed to replicate the actions of the animal’s own immune system to fight infections.
Faster healing is achieved when wounds are cleaned and maintained moist. This product has proven facts of non-toxic, broad spectrum antimicrobial in vitro killing bacteria, fungi, spores and viruses including MRSA, E. coli and staph in 30 seconds. Vetericyn is safe enough to use as an eye and ear animal rinse.
Our technology is available in products for both animals and humans.
Innovacyn's wound and infection products are proudly made in the USA. Over two million human patients have been safely treated by our technology worldwide.
vetericyn.com/
www.apwca.org/abstracts/abstract.cfm?ID=273
Title: Cost Effective use of Hypochlorous Acid and its Impact on Bioburden in a Clinical Setting
- Mar 31, 2011
Author(s) Gregory A Bohn
Presented at: APWCA 2011 National Conference
Background
With ever increasing attention on bioburden and emergence of resistant bacteria, our hospital clinic has encouraged a policy of culturing wounds at the time of presentation. Knowing that wounds contain biofilms that harbor bacteria, the dilemma arises then as to whether to treat a wound with antimicrobial dressings or antibiotics when bacteria are identified.
Hypochlorous acid is a product of the neutrophilic oxidative burst process that occurs as part of our immune systems response to invading pathogens.
A product of myeloperoxidase catalyzation within a phagolyposome of the neutrophil, Hypochlorous acid is a potent microbicidal agent.
It has significant activity against a wide variety of aerobic, anaerobic, fungal and viral pathogens.
Hypochlorous acid has been shown to be effective within seconds of exposure to pathogens making it an attractive topical treatment in wound care. Bacterial resistance to antibiotics continues to be problematic as emergence of resistance is common.
1 The topical use of broad spectrum antibiotics is not recommended due to the risk of allergic reaction, greater effect on endogenous microflora, induction of resistance, and reduced therapeutic efficacy.
Similarly, other topical antimicrobial agents have cytotoxic effects and impair wound healing.
2 The ability to penetrate and degrade biofilm formation and the bioburden contained within is an advantageous effect in wound care.
3 We review the effect the use of hypochlorous acid on bioburden and biofilm as monitored in our clinic and compare that to the cost of antimicrobial dressing use.
Methods Results Conclusion
1. 1.) Bergstrom N, Bennett MA, Carlson CE, et al. Treatment of Pressure Ulcers. Clinical Practice Guideline, 2. 2.) Wang L, Bassiri M, Naijafi R, Najafi K, Yang J, Khosrovi B, Hwong W, Barati E, Belisle B, Celeri C, Robson MC. Hypochlorous Acid as a PotentialWound Care Agent Part I. Stabilized Hypochlorous Acid: A Component of the Inorganic Armamentarium of Innate Immunity. Journ Burns and Wounds Vol 6 Apr 2007 pp 65-79. 3. 3.) Robson MC, Payne WG, et al. Hypochlorous Acid as a PotentialWound Care Agent Part II. Stabilized Hypochlorous Acid: Its Role in Decreasing Tissue Bacterial Bioburden and Overcoming the Inhibition of Infection on Wound Healing. Journ Burns and Wounds vol 6 Apr 2007 pp 80-90 4. 4.) Selkon JB, Cherry GW, Wilson JM, Hughes MA, Evaluation of hypochlorous acid washes in the treatment of chronic venous leg ulcers. Journal of Wound Care Vol 15 No1 Jan 2006 pp 33-37. 5. 5.) Woo KY, Sibbald RG, A Cross-sectional Validation Study of Using NERDS and STONEES to Assess Bacterial Burden. Ostomy Wound Management 55(8) 2009. Pp 40-48.